Kara Pearson
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Spectroscopy top 10%
- Mass Spectrometry Techniques and Applications
- Advanced Proteomics Techniques and Applications
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
-
- Drug-Induced Hepatotoxicity and Protection 4
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Henry M. Fales (2 shared papers)Lewis K. Pannell (1 shared paper)Tabassome Simon (1 shared paper)Frank LaCreta (1 shared paper)L. Bergougnan (1 shared paper)Fabrice Hurbin (1 shared paper)Frank D. Sistare (5 shared papers)Deepak L. Bhatt (1 shared paper)
- Journals
- Toxicological Sciences (3 papers)Toxicology and Applied Pharmacology (1 paper)Journal of the American Society for Mass Spectrometry (1 paper)Analytical Chemistry (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesAustraliaMalaysia
In The Last Decade
Kara Pearson
15 papers receiving 301 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 62
- Spectroscopy 73
- Internal Medicine 12
- Cardiology and Cardiovascular Medicine 62
- Biological Psychiatry 6
Countries citing papers authored by Kara Pearson
This map shows the geographic impact of Kara Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Pearson more than expected).
Fields of papers citing papers by Kara Pearson
This network shows the impact of papers produced by Kara Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Pearson. The network helps show where Kara Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Kara Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 94 | |
| 2 | 2011 | 69 | |
| 3 | 2021 | 32 | |
| 4 | 2020 | 28 | |
| 5 | 2011 | 22 | |
| 6 | 2019 | 16 | |
| 7 | 2019 | 15 | |
| 8 | 2013 | 8 | |
| 9 | 2019 | 7 | |
| 10 | 2020 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2002 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2022 | 1 |
About Kara Pearson
Kara Pearson is a scholar working on Oncology, Pharmacology, Molecular Biology, Spectroscopy and Cancer Research, having authored 15 papers that have together received 311 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Mass Spectrometry Techniques and Applications (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), HIV Research and Treatment (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Pharmacology (62 citations), Spectroscopy (73 citations), Internal Medicine (12 citations), Cardiology and Cardiovascular Medicine (62 citations) and Biological Psychiatry (6 citations). Kara Pearson has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Henry M. Fales, Lewis K. Pannell, Tabassome Simon, Frank LaCreta, L. Bergougnan, Fabrice Hurbin, Frank D. Sistare, Deepak L. Bhatt, Éric Vicaut and M. Dubar. Their work appears in journals such as Toxicological Sciences, Toxicology and Applied Pharmacology, Journal of the American Society for Mass Spectrometry, Analytical Chemistry and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.